Polymorphisms Associated with Cholesterol and Risk of Cardiovascular Events
Top Cited Papers
- 20 March 2008
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 358 (12) , 1240-1249
- https://doi.org/10.1056/nejmoa0706728
Abstract
Common single-nucleotide polymorphisms (SNPs) that are associated with blood low-density lipoprotein (LDL) or high-density lipoprotein (HDL) cholesterol modestly affect lipid levels. We tested the hypothesis that a combination of such SNPs contributes to the risk of cardiovascular disease. We studied SNPs at nine loci in 5414 subjects from the cardiovascular cohort of the Malmö Diet and Cancer Study. We first validated the association between SNPs and either LDL or HDL cholesterol and subsequently created a genotype score on the basis of the number of unfavorable alleles. We used Cox proportional-hazards models to determine the time to the first cardiovascular event in relation to the genotype score. All nine SNPs showed replication of an association with levels of either LDL or HDL cholesterol. With increasing genotype scores, the level of LDL cholesterol increased from 152 mg to 171 mg per deciliter (3.9 to 4.4 mmol per liter), whereas HDL cholesterol decreased from 60 mg to 51 mg per deciliter (1.6 to 1.3 mmol per liter). During follow-up (median, 10.6 years), 238 subjects had a first cardiovascular event. The genotype score was associated with incident cardiovascular disease in models adjusted for covariates including baseline lipid levels (P<0.001). The use of the genotype score did not improve the clinical risk prediction, as assessed by the C statistic. However, there was a significant improvement in risk classification with the use of models that included the genotype score, as compared with those that did not include the genotype score. A genotype score of nine validated SNPs that are associated with modulation in levels of LDL or HDL cholesterol was an independent risk factor for incident cardiovascular disease. The score did not improve risk discrimination but did modestly improve clinical risk reclassification for individual subjects beyond standard clinical factors.Keywords
This publication has 33 references indexed in Scilit:
- Combined Analysis of SixLipoprotein LipaseGenetic Variants on Triglycerides, High-Density Lipoprotein, and Ischemic Heart Disease: Cross-Sectional, Prospective, and Case-Control Studies from the Copenhagen City Heart StudyJournal of Clinical Endocrinology & Metabolism, 2006
- A Spectrum of PCSK9 Alleles Contributes to Plasma Levels of Low-Density Lipoprotein CholesterolAmerican Journal of Human Genetics, 2006
- Polymorphism inAPOBAssociated with Increased Low-Density Lipoprotein Levels in Both Genders in the General PopulationJournal of Clinical Endocrinology & Metabolism, 2005
- Cholesteryl Ester Transfer Protein TaqIB Variant, High-Density Lipoprotein Cholesterol Levels, Cardiovascular Risk, and Efficacy of Pravastatin TreatmentCirculation, 2005
- Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general populationJournal of Clinical Investigation, 2004
- Association and linkage of LDLR gene variation with variation in plasma low density lipoprotein cholesterolJournal of Human Genetics, 1998
- A hepatic lipase ( LIPC ) allele associated with high plasma concentrations of high density lipoprotein cholesterolProceedings of the National Academy of Sciences, 1997
- The collaborative Lipid Research Clinics family study: Biological and cultural determinants of familial resemblance for plasma lipids and lipoproteinsGenetic Epidemiology, 1985
- HIGH-DENSITY LIPOPROTEIN AND ATHEROSCLEROSISThe Lancet, 1975
- Factors of Risk in the Development of Coronary Heart Disease—Six-Year Follow-up ExperienceAnnals of Internal Medicine, 1961